期刊文献+

浙江省台州地区6014例女性宫颈人乳头瘤病毒感染情况及流行病学分析 被引量:9

Epidemiological features of cervical human papilloma virus infection among 6014 women in Taizhou
原文传递
导出
摘要 目的了解浙江台州地区女性宫颈人乳头瘤病毒(HPV)感染率以及基因亚型的分布特征。方法采用液相芯片技术对浙江省台州医院妇科门诊就诊患者的宫颈脱落细胞共6 014例进行HPV基因分型检测,并对该地区女性HPV感染率、基因亚型分布等进行分析。采用SPSS 16.0软件对所得资料进行统计,组间率的比较用χ2检验,P〈0.05为差异有统计学意义。结果浙江台州地区女性HPV总感染率为22.15%(1 332/6 014),单一型感染率为16.53%(994/6 014),多重感染率为5.62%(338/6 014)。HPV阳性患者中高危型HPV感染次数占86.01%(1 537/1 787),感染率从高到低依次为HPV52(17.80%)、HPV16(11.86%)、HPV58(10.24%)、HPV56(5.74%)和HPV18(5.54%)。51~60岁组感染率(29.58%)与总感染率(22.15%)比较差异有统计学意义(P〈0.05),且不同年龄组女性宫颈HPV感染各亚型分布情况差异有统计学意义。结论浙江省台州地区女性HPV感染率较高,且以高危型HPV52、16、58感染为主,要重视老年妇女的高危型HPV感染。 Objective To understand the epidemiological features of cervical human papilloma virus(HPV)infection in women in Taizhou. Methods A total of 6 014samples of cervical smear collected from female outpatients visited gynecologic clinics in Taizhou hospital for the identification of HPV genotype by using xMAP of Luminex 200TM as well as to analyze the infection rate and the distribution of HPV genotypes.All statistical analyses were performed under SPSS 16.0.Chi-square test was used to analyze data. Results The overall prevalence of HPV infection was 22.15%(1 332/6 014)with 16.53%(994/6 014)of single infection and5.62%(338/6 014)of co-infection.Among HPV positive patients,86.01%(1 537/1 787)was found to be high-risk infection.HPV 52was identified as the most prevalent genotype(17.80%),followed by HPV16(11.86%),HPV58(10.24%),HPV56(5.74%)and HPV18(5.54%).The infection rate was the highest among women aged 51-60years which had significant difference compared with the total infection rate(29.58%vs 22.15%)(P<0.05).Also,the genotype was different among female age groups. Conclusions This study provides baseline data on HPV prevalence among women in Taizhou of Zhejiang province,China.Low prevalence of HPV vaccine types and relatively high prevalence of HPV52,HPV16and HPV58are observed,indicating that high-risk types of HPV infection among older women need to be under surveillance.
出处 《中国预防医学杂志》 CAS 2014年第4期309-313,共5页 Chinese Preventive Medicine
基金 国家自然科学基金(81102218 31170879)
关键词 人乳头瘤病毒 基因分型 宫颈 流行病学 Human papilloma virus Genotype Cervix Epidemiology
  • 相关文献

参考文献17

  • 1Trottier H, Franco EL. The epidemiology of genital human papillomavirus infection[J]. Vaccine, 2006, 24 Suppl 1 : S1-S15.
  • 2Rey-Ares L, Ciapponi A, Pichon-Riviere A. Efficacy and safety of human papilloma virus vaccine in cervical cancer prevention: systematic review and metmanalysis [J]. Arch Argent Pediatr, 2012, 110 (6): 483-489.
  • 3Schiffman M, Castle PE, Jeronimo J, et al. Human papil lomavirus and cervical cancer EJ]. The Lancet, 2007, 370 (9590): 890-907.
  • 4Wang S, Wei H, Wang N, etal. The prevalence and role of human papilIomavirus genotypes in primary cervical.screening in the northeast of China [J] .BMC Cancer, 2012, 12 (1): 160.
  • 5Zhao R, Zhang WY, Wu MH, etal. Human papillomavir us infection in Beijing, People's Republic of China: a popu- lation-based study [J].Br J Cancer, 2009, 101 (9): 1635-1640.
  • 6Shen Y, Gong JM, Li YQ, etal. Epidemiology and geno- type distribution of human papillomavirus (HPV) in women of Henan Province, China [J]. Clin Chim Acta, 2013, 415 (1): 297 -301.
  • 7Chen Q, Luo ZY, Lin M, et al. Prevalence and genotype distribution of human papillomavirus infections in women at- tending hospitals in Chaozhou of Guangdong Province [J]. Asian Pac J Cancer Prey, 2012, 13 (4): 1519-1524.
  • 8Sun LL, Jin Q, Li H, etal. Population based study on the prevalence of and risk factors for human papillomavirus in- fection in Qujing of Yunnan province, Southwest China [J]. Virol J, 2012, 9 (1): 153.
  • 9de Sanjos6 S, Diaz M, Castellsagu6 X, et al. Worldwide preva- lence and genotype distribution of cervical human papillomavirus DNA in women with normal cytology: a meta-analysis [J]. Lancet Infect Dis, 2007, 7 (7): 453 -459.
  • 10Inoue M, Sakaguchi J, Sasagawa T, et al. The evaluation of human papillomavirus DNA testing in primary screening for cervical lesions in a large Japanese population [J]. Int J GynecolCancer, 2006, 16 (3): 1007- 1013.

同被引文献81

  • 1杨英捷,赵健,李雪倩,廖秦平.2285例女性下生殖道人乳头状瘤病毒感染筛查结果分析[J].中国实用妇科与产科杂志,2006,22(6):444-445. 被引量:95
  • 2Walboomers JM,Jacobs MV,Manos MM,et al. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide [ J ]. J Pathol, 1999,159 ( 1 ) : 12 - 19.
  • 3Herrero R, Castle PE, Schiffman M , et al. Epidemiologic profile of type - specific human papilloma virus infection and cervical neoplasia in Guanacaste, Costa Riea [ J ]. J Infect Dis, 2005,191 ( 11 ) : 1787 - I799.
  • 4International Agency for Research on Cancer. GLOBOCAN 2012 : estimated cancer incidence, mortality and prevalence worldwide in 2012. Lyon, France: International Agency for Research on Cancer/World Health Organization, 2012.
  • 5Saslow D, Solomon D, Lawson HW, et al. American Cancer Society, American Society for Colposcopy and Cervical Pathology, and American Society for Clinical Pathology screening guidelines for the prevention and early detection of cervical cancer. Am J Clin Pathol, 2012, 137:516-542. doi: 10. 1309/ AJCPTGD94EVRSJCG.
  • 6Xu HH, Shi WW, Lin A, et al. HLA-G 3" untranslated region polymorphisms influence the susceptibility for human papillomavirus infection. Tissue Antigens, 2014, 84:216-222. doi: 10. llll/tan. 12359.
  • 7De Sanjose S, Quint WG, Alemany L. Retrospective International Survey and HPV Time Trends Study Group. Human papillomavirus genotype attribution in invasive cross-sectional worldwide study. cervical cancer: a retrospective Lancet Oncol, 2010, 11 : 1048-1066. doi: 10. 1016/S1470-2045(10)70230-8.
  • 8Kjaer SK, Frederiksen K, Munk C, et al. Long-term absolute risk of cervical intraepithelial neoplasia grMe 3 or worse following human papillomavirus infection: role of persistence. J Natl Cancer Inst, 20|0, 102:1478-1d88. doi: 10. 1093/jnci/djq356.
  • 9Castle PE, Stoler MH, Wright TC, et al. Performance of carcinogenic human papillomavirus (HPV) testing and HPVI6 or HPV18 genotyping for cervical cancer screening of women aged 25 years and older: a subanalysis of the ATHENA study. Lancet Oncol, 2011, 12: 880-890. doi: 10. 1016/S1470-2045 ( ll ) 70188-7.
  • 10De Sanjose S, Quint WG, Alemany L, et al. Hunrn papitlomavius genotype attribution in invasive cervical cancer: a retrospeetive cross-sectional worldwide study. Lancet Oncol, 2010,11: 1048- 1056. doi : 10. 1016/$1470-2045 ( 10)70230-8.

引证文献9

二级引证文献52

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部